⌘K

Login Start Free

Home/Filings/4/0001127602-22-022049

4//SEC Filing

SMITH SANDFORD D 4

Accession 0001127602-22-022049

CIK 0001061983other

View on SEC.gov Company Profile

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 6:29 PM ET

Size

14.7 KB

Accession

0001127602-22-022049

Insider Transaction Report

Form 4

Period: 2022-09-02

CYTOKINETICS INCCYTK

SMITH SANDFORD D

Director

Transactions

Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2022-09-02−3,035→ 0 total
Exercise: $10.68From: 2019-06-15Exp: 2029-05-15→ Common Stock (3,035 underlying)
Exercise/Conversion
Common Stock
2022-09-02$10.68/sh+3,035$32,414→ 15,205 total
Exercise/Conversion
Common Stock
2022-09-02$37.89/sh+2,500$94,725→ 23,539 total
Sale
Common Stock
2022-09-02$53.97/sh−11,369$613,585→ 12,170 total
Exercise/Conversion
Common Stock
2022-09-02$24.32/sh+5,834$141,883→ 21,039 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2022-09-02−5,834→ 0 total
Exercise: $24.32From: 2021-06-12Exp: 2031-05-12→ Common Stock (5,834 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2022-09-02−2,500→ 7,500 total
Exercise: $37.89From: 2022-06-10Exp: 2032-05-10→ Common Stock (2,500 underlying)

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1

filerCIK 0001243004

Filing Metadata

Form type: 4
Filed: Sep 1, 8:00 PM ET
Accepted: Sep 2, 6:29 PM ET
Size: 14.7 KB

View on SEC.gov